ARDX
Ardelyx Inc
Price:  
5.62 
USD
Volume:  
3,953,385.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Ardelyx EV/EBITDA

-187.4%
Upside

As of 2024-07-27, the EV/EBITDA ratio of Ardelyx Inc (ARDX) is -24.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Ardelyx's latest enterprise value is 1,378.65 mil USD. Ardelyx's TTM EBITDA according to its financial statements is -57.15 mil USD. Dividing these 2 quantities gives us the above Ardelyx EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 12.2x - 21.5x 16.6x
Forward P/E multiples 17.8x - 24.1x 21.4x
Fair Price (4.62) - (5.52) (4.91)
Upside -182.2% - -198.3% -187.4%
5.62 USD
Stock Price
(4.91) USD
Fair Price

Ardelyx EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-07-26 -24.12
2024-07-25 -23.59
2024-07-24 -24.12
2024-07-23 -24.41
2024-07-22 -24.45
2024-07-19 -23.67
2024-07-18 -23.59
2024-07-17 -24.65
2024-07-16 -26.54
2024-07-15 -25.47
2024-07-12 -25.23
2024-07-11 -24.94
2024-07-10 -23.88
2024-07-09 -23.88
2024-07-08 -23.43
2024-07-05 -22.77
2024-07-03 -22.89
2024-07-02 -22.73
2024-07-01 -32.11
2024-06-28 -31.45
2024-06-27 -27.72
2024-06-26 -26.13
2024-06-25 -25.76
2024-06-24 -26.70
2024-06-21 -26.33
2024-06-20 -25.23
2024-06-18 -25.47
2024-06-17 -26.87
2024-06-14 -27.11
2024-06-13 -27.68
2024-06-12 -28.50
2024-06-11 -28.26
2024-06-10 -27.56
2024-06-07 -27.52
2024-06-06 -28.71
2024-06-05 -30.30
2024-06-04 -29.24
2024-06-03 -29.44
2024-05-31 -29.20
2024-05-30 -28.87
2024-05-29 -28.18
2024-05-28 -29.36
2024-05-24 -28.75
2024-05-23 -31.57
2024-05-22 -33.13
2024-05-21 -32.72
2024-05-20 -33.58
2024-05-17 -33.09
2024-05-16 -33.01
2024-05-15 -33.25